Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Aezs-130
2. Aib-dtrp-dgtrp-cho
3. Aib-trp-gtrp-cho
4. Aminoisobutyryl-tryptophyl-tryptophanamine-formyl
5. Ard-07
6. Ep 1572
7. Ep-1572
8. Ep1572
9. Jmv 1843
10. Jmv-1843
11. Jmv1843
12. Macimorelin Acetate
13. Macrilen
1. Ard-07
2. Aezs-130
3. 381231-18-1
4. Ep-1572
5. Jmv-1843
6. Ard 07
7. Jmv 1843
8. Ep 1572
9. Ep-01572
10. Chembl278623
11. 381231-18-1 (free Base)
12. Ep1572
13. Macimorelin (usan)
14. 8680b21w73
15. Macimorelin [usan]
16. D-87575
17. 2-amino-n-((r)-1-(((r)-1-formamido-2-(1h-indol-3-yl)ethyl)amino)-3-(1h-indol-3-yl)-1-oxopropan-2-yl)-2-methylpropanamide
18. 2-amino-n-[(2r)-1-[[(1r)-1-formamido-2-(1h-indol-3-yl)ethyl]amino]-3-(1h-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide
19. Macimorelin [inn]
20. Macimorelin [usan:inn]
21. Unii-8680b21w73
22. Aib-dtrp-dgtrp-cho
23. Macimorelin [mi]
24. Aezs130
25. Macimorelin [who-dd]
26. Gtpl9745
27. Schembl1984708
28. Jmv1843
29. Umv1843
30. Dtxsid601045766
31. Glxc-25240
32. Bdbm50125886
33. Db13074
34. Ep01572
35. Hy-14820
36. Cs-0003577
37. D10563
38. Aminoisobutyryl-tryptophyl-tryptophanamine-formyl
39. Q15624037
40. 2-amino-n-{(r)-1-[(r)-1-formylamino-2-(1h-indol-3-yl)-ethylcarbamoyl]-2-1h-indol-3-yl-ethyl}-2-methyl-propionamide
41. N(sup 2)-(2-amino-2-methylpropanoyl-n1-((1r)-1-formamido-2-(1h-indol-3-yl)ethyl)-d-tryptophanamide
Molecular Weight | 474.6 g/mol |
---|---|
Molecular Formula | C26H30N6O3 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 474.23793884 g/mol |
Monoisotopic Mass | 474.23793884 g/mol |
Topological Polar Surface Area | 145 Ų |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 761 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Indicated for the diagnosis of adult growth hormone deficiency (AGHD).
FDA Label
This medicinal product is for diagnostic use only. GHRYVELIN is indicated for the diagnosis of growth hormone deficiency (GHD) in adults.
Diagnosis of growth hormone deficiency
Maximum GH levels from stimulation are observed between 30 to 90 minutes after administration of macimorelin. Increase in the QTcF interval may be observed from macimorelin administration.
V04CD06
V - Various
V04 - Diagnostic agents
V04C - Other diagnostic agents
V04CD - Tests for pituitary function
V04CD06 - Macimorelin
Absorption
Macimorelin is a novel, synthetic ghrelin agonist, which is readily absorbed from the gastrointestinal tract. The maximum plasma concentration (Cmax) was observed between 0.5 and 1.5 hours following oral administration of 0.5mg/kg macimorelin to patients with AGHD under fasting for at least 8 hours. Higher doses of drug demonstrate a dose-proportional increase in plasma concentrations. A liquid meal decreased the macimorelin Cmax and AUC by 55% and 49%, respectively.
Volume of Distribution
Following a single oral dose of 0.5 mg/kg macimorelin, the mean volume of distribution of the central compartment is 5,733.4 565.7L.
Clearance
Following a single oral dose of 0.5 mg/kg macimorelin, the mean clearance over the fraction absorbed (Cl/F) was 37,411.0 4,554.6 mL/min.
Macimorelin predominantly undergoes CYP3A4-mediated metabolism according to an *in vitro* human liver microsomes study.
The mean terminal half-life (T1/2) is 4.1 hours following administration of a single oral dose of 0.5 mg macimorelin/kg body weight in healthy subjects.
Ghrelin is an endogenous ligand for the GH secretagogue receptor that is also called the ghrelin receptor (GHS-R1a). Upon activation of the receptor, ghrelin serves to increase growth hormone (GH) secretion. Macimorelin mimics the actions of ghrelin by stimulating GH release. As a synthetic agonist, it activates growth hormone secretagogue receptors present in the pituitary and hypothalamus.
Related Excipient Companies
Excipients by Applications
Global Sales Information
ABOUT THIS PAGE
A Macimorelin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Macimorelin, including repackagers and relabelers. The FDA regulates Macimorelin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Macimorelin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Macimorelin supplier is an individual or a company that provides Macimorelin active pharmaceutical ingredient (API) or Macimorelin finished formulations upon request. The Macimorelin suppliers may include Macimorelin API manufacturers, exporters, distributors and traders.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Macimorelin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Macimorelin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Macimorelin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Macimorelin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Macimorelin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Macimorelin suppliers with NDC on PharmaCompass.
Macimorelin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Macimorelin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Macimorelin GMP manufacturer or Macimorelin GMP API supplier for your needs.
A Macimorelin CoA (Certificate of Analysis) is a formal document that attests to Macimorelin's compliance with Macimorelin specifications and serves as a tool for batch-level quality control.
Macimorelin CoA mostly includes findings from lab analyses of a specific batch. For each Macimorelin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Macimorelin may be tested according to a variety of international standards, such as European Pharmacopoeia (Macimorelin EP), Macimorelin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Macimorelin USP).
LOOKING FOR A SUPPLIER?